Loading…
Peripheral Arterial Stiffness and Endothelial Dysfunction in Idiopathic and Scleroderma Associated Pulmonary Arterial Hypertension
Objective. Pulmonary endothelial dysfunction and increased reflection of pulmonary pressure waves have been reported in pulmonary arterial hypertension (PAH). However, the systemic vascular involvement is not fully understood. Our study focused on the systemic arterial stiffness and endothelial invo...
Saved in:
Published in: | Journal of rheumatology 2009-05, Vol.36 (5), p.970-975 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective. Pulmonary endothelial dysfunction and increased reflection of pulmonary pressure waves have been reported in pulmonary arterial
hypertension (PAH). However, the systemic vascular involvement is not fully understood. Our study focused on the systemic
arterial stiffness and endothelial involvement in idiopathic and scleroderma associated PAH.
Methods. Peripheral arterial stiffness and endothelial function were evaluated in 38 patients with idiopathic (n = 28) and scleroderma
associated (n = 10) PAH, and 21 control subjects (13 healthy; 8 with scleroderma and normal pulmonary pressure). All participants
underwent clinical and cardiopulmonary evaluation. Arterial stiffness was measured through the fingertip tonometry derived
augmentation index (AI), which is the boost increase in the late systolic pressure wave after the initial systolic shoulder.
Endothelial function was measured by forearm blood flow dilatation response to brachial artery occlusion by a noninvasive
plethysmograph (EndoPAT 2000), which is associated with nitric oxide-dependent vasodilatation and yields a peripheral arterial
tone (PAT) ratio.
Results. Mean systolic pulmonary pressure was 70.5 ± 21.6 mm Hg (idiopathic-PAH) and 69.3 ± 20 mm Hg (scleroderma-PAH). AI was higher
in scleroderma patients (10.5% ± 19.6% in healthy controls, 9.0% ± 21.5% in idiopathic-PAH, 20.1% ± 19.1% in scleroderma-PAH,
and 24.4% ± 18.9% in scleroderma-controls; nonsignificant). PAT ratio was significantly lower (p < 0.05) than control values
in idiopathic-PAH and scleroderma-PAH (PAT ratio: control 2.20 ± 0.25; idiopathic 1.84 ± 0.51; scleroderma 1.66 ± 0.66). AI
was not correlated to endothelial dysfunction. There were no differences between the 2 PAH patient groups in age, body mass
index, New York Heart Association classification, or 6-min walk test.
Conclusion. Our study shows a trend towards increased arterial stiffness in scleroderma (nonsignificant), and also peripheral endothelial
dysfunction in idiopathic-PAH and in scleroderma-PAH. These findings suggest involvement of different vessels in scleroderma-PAH
compared to idiopathic-PAH. |
---|---|
ISSN: | 0315-162X 1499-2752 |
DOI: | 10.3899/jrheum.081088 |